SynerGene Therapeutics, Inc.

Biotechnology company · Potomac, Maryland, United States

SynerGene Therapeutics, Inc. is a biotechnology company headquartered in Potomac, Maryland, United States. It has received 15 US government small-business research awards (SBIR/STTR) from health agencies, $5.9 million in total, most recently in 2014. It has reported private securities offerings to the US SEC, most recently $6.4 million sold in a notice filed in 2014.

Profile compiled from public records. Is this your company? Request a correction or update

SynerGene Therapeutics at a glance

Typebiotechnology company
HeadquartersPotomac, Maryland, United States
Employees (self-reported, 2014)3
SEC CIK1091006

What does SynerGene Therapeutics do?

US government research funding

15 SBIR/STTR small-business research awards from US health agencies, $5.9 million in total (1999 to 2014).

Private fundraising reported to the SEC

6 Form D notices; the most recent reported $6.4 million sold (2014).

Frequently asked questions about SynerGene Therapeutics

Where is SynerGene Therapeutics headquartered?

SynerGene Therapeutics, Inc. is headquartered in Potomac, Maryland, United States.

What does SynerGene Therapeutics do?

SynerGene Therapeutics, Inc. is a biotechnology company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences